Sandbox 09232014: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 8: | Line 8: | ||
| style="background: #DCDCDC; padding: 5px 5px; font-weight: bold;" valign=top | Exanthems | | style="background: #DCDCDC; padding: 5px 5px; font-weight: bold;" valign=top | Exanthems | ||
| style="background: #F5F5F5; padding: 5px 5px;" valign=top | Delayed-type hypersensitivity <BR> Evolve over days after drug initiation <BR> Diffuse macules and papules | | style="background: #F5F5F5; padding: 5px 5px;" valign=top | Delayed-type hypersensitivity <BR> Evolve over days after drug initiation <BR> Diffuse macules and papules | ||
| style="background: #F5F5F5; padding: 5px 5px;" valign=top | [[ | | style="background: #F5F5F5; padding: 5px 5px;" valign=top | [[Allopurinol]], [[amphotericin]], [[barbiturates]], [[captopril]], [[carbamazepine]], [[cephalosporins]], [[chloramphenicol]], [[erythromycin]], [[furosemide]], [[gentamicin]], [[gold salts]], [[lithium]], [[nalidixic acid]], [[nitrofurantoin]], [[penicillins]], [[phenothiazines]], [[phenylbutazone]], [[phenytoin]], [[sulfonamides]]), [[thiazides]] | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px 5px; font-weight: bold;" valign=top | Urticaria/ angioedema | | style="background: #DCDCDC; padding: 5px 5px; font-weight: bold;" valign=top | Urticaria/ angioedema | ||
| style="background: #F5F5F5; padding: 5px 5px;" valign=top | Often IgE mediated <BR> Onset within minutes of drug initiation | | style="background: #F5F5F5; padding: 5px 5px;" valign=top | Often IgE mediated <BR> Onset within minutes of drug initiation | ||
| style="background: #F5F5F5; padding: 5px 5px;" valign=top | [[ | | style="background: #F5F5F5; padding: 5px 5px;" valign=top | [[ACE inhibitors]], [[aminosalicylic acid]], [[anticonvulsants]], [[aspirin]], [[atropine]], [[cephalosporins]], [[dextran]], [[hydralazine]], [[monoclonal antibodies]], [[NSAIDs]], [[opioids]], [[penicillins]], [[pentamidine]], [[quinine]], [[sulfonamides]], [[tetracyclines]], [[thiouracil]], [[tubocurarine]], [[vancomycin]] | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px 5px; font-weight: bold;" valign=top | Fixed drug eruption | | style="background: #DCDCDC; padding: 5px 5px; font-weight: bold;" valign=top | Fixed drug eruption | ||
| style="background: #F5F5F5; padding: 5px 5px;" valign=top | Hyperpigmented plaques that recur at same skin or mucosal site | | style="background: #F5F5F5; padding: 5px 5px;" valign=top | Hyperpigmented plaques that recur at same skin or mucosal site | ||
| style="background: #F5F5F5; padding: 5px 5px;" valign=top | [[NSAIDs]], [[ | | style="background: #F5F5F5; padding: 5px 5px;" valign=top | [[ACE inhibitors]], [[allopurinol]], [[amlodipine]], [[aspirin]], [[barbiturates]], [[benzodiazepines]], [[carbamazepine]], [[cephalosporins]], [[clindamycin]], [[co-trimoxazole]], [[dextromethorphan]], [[diltiazem]], [[fluconazole]], [[lamotrigine]], [[lansoprazole]], [[metronidazole]], [[NSAIDs]], [[paclitaxel]], [[paracetamol]], [[penicillin]], [[phenolphthalein]][[omeprazole]], [[quinine]], [[salicylates]], [[sulfonamides]], [[terbinafine]], [[tetracyclines]], [[trimethoprim]] | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px 5px; font-weight: bold;" valign=top | Pustules | | style="background: #DCDCDC; padding: 5px 5px; font-weight: bold;" valign=top | Pustules | ||
Line 33: | Line 33: | ||
| style="background: #DCDCDC; padding: 5px 5px; font-weight: bold;" valign=top | Stevens-Johnson syndrome (SJS) | | style="background: #DCDCDC; padding: 5px 5px; font-weight: bold;" valign=top | Stevens-Johnson syndrome (SJS) | ||
| style="background: #F5F5F5; padding: 5px 5px;" valign=top | Purpuric macules on face and trunk with <10% epidermal detachment, fever, stomatitis, ocular involvement | | style="background: #F5F5F5; padding: 5px 5px;" valign=top | Purpuric macules on face and trunk with <10% epidermal detachment, fever, stomatitis, ocular involvement | ||
| style="background: #F5F5F5; padding: 5px 5px;" valign=top | [[ | | style="background: #F5F5F5; padding: 5px 5px;" valign=top | [[antibiotics]], [[barbiturates]], [[Beta-lactam|β-lactam antibiotics]], [[carbamazepine]], [[chlorpropamide]], [[co-trimoxazole]], [[gold]], [[H2-antagonist]], [[histamine]], [[lamotrigine]], [[leflunomide]], [[macrolides]], [[mefloquine]], [[NSAIDs]], [[phenothiazines]], [[phenytoin]], [[rifampicin]], [[sulfonamides]], [[tetracyclines]], [[thiazides]] | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px 5px; font-weight: bold;" valign=top | Toxic epidermal necrolysis (TEN) | | style="background: #DCDCDC; padding: 5px 5px; font-weight: bold;" valign=top | Toxic epidermal necrolysis (TEN) | ||
Line 79: | Line 79: | ||
| style="background: #DCDCDC; padding: 5px 5px; font-weight: bold;" valign=top | Vasculitis | | style="background: #DCDCDC; padding: 5px 5px; font-weight: bold;" valign=top | Vasculitis | ||
| style="background: #F5F5F5; padding: 5px 5px;" valign=top | Cutaneous or visceral vasculitis | | style="background: #F5F5F5; padding: 5px 5px;" valign=top | Cutaneous or visceral vasculitis | ||
| style="background: #F5F5F5; padding: 5px 5px;" valign=top | [[ | | style="background: #F5F5F5; padding: 5px 5px;" valign=top | [[Allopurinol]], [[aspirin]], [[Beta-lactam|β-lactam antibiotics]], [[carbamazepine]], [[carbimazole]], [[co-trimoxazole]], [[diltiazem]], [[erythromycin]], [[furosemide]], [[gold]], [[G-CSF]], [[GM-CSF]], [[hydralazine]], [[interferons]], [[methotrexate]], [[minocycline]], [[NSAIDs]], [[penicillamine]], [[propylthiouracil]], [[retinoids]], [[sulfasalazine]], [[sulfonamides]], [[thiazides]], [[thrombolytics]] | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px 5px; font-weight: bold;" valign=top | Serum sickness | | style="background: #DCDCDC; padding: 5px 5px; font-weight: bold;" valign=top | Serum sickness |
Revision as of 19:50, 23 September 2014
Organ-specific reactions | Clnical features | Implicated medications |
---|---|---|
Pulmonary | Pulmonary fibrosis, hypersensitivity pneumonitis | Nitrofurantoin, bleomycin, methotrexate |
Hepatic | Hepatitis, cholestasis | Para-aminosalicylic acid, sulfonamides, phenothiazines |
Renal | Interstitial nephritis, membranous glomerulonephritis | Penicillin, sulfonamides, gold, penicillamine, allopurinol |
Hematologic | Hemolytic anemia, thrombocytopenia, granulocytopenia | Penicillin, quinine, sulfonamides |
Multiorgan reactions | Clnical features | Implicated medications |
---|---|---|
Anaphylaxis | Urticaria, angioedema, bronchospasm, gastrointestinal symptoms, hypotension | β-lactam antibiotics, monoclonal antibodies |
Systemic lupus erythematosus | Arthralgia, myalgias, fever, malaise | Hydralazine, procainamide, isoniazid |
Vasculitis | Cutaneous or visceral vasculitis | Allopurinol, aspirin, β-lactam antibiotics, carbamazepine, carbimazole, co-trimoxazole, diltiazem, erythromycin, furosemide, gold, G-CSF, GM-CSF, hydralazine, interferons, methotrexate, minocycline, NSAIDs, penicillamine, propylthiouracil, retinoids, sulfasalazine, sulfonamides, thiazides, thrombolytics |
Serum sickness | Urticaria, arthralgia, fever | Heterologous antibodies, infliximab |
Drug reaction with eosinophilia and systemic symptoms (DRESS) | Cutaneous eruption, fever, eosinophilia, hepatic dysfunction, lymphadenopathy | Anticonvulsants, sulfonamides, minocycline, allopurinol |